{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:36:15Z","timestamp":1788831375695,"version":"build-2803163510"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.suc.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T09:53:57Z","timestamp":1572342837000},"page":"43-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pathology of Melanoma"],"prefix":"10.1016","volume":"100","author":[{"given":"Asmita","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma N.M.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2019.09.004_bib1","unstructured":"American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018."},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00008390-200506000-00012","article-title":"Cutaneous, ocular and visceral melanoma in African Americans and Caucasians","volume":"15","author":"Tsai","year":"2005","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaad.2016.06.006","article-title":"Racial disparities in melanoma survival","volume":"75","author":"Dawes","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2019.09.004_bib4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ydbio.2018.03.024","article-title":"The issue of the multipotency of the neural crest cells","volume":"444","author":"Dupin","year":"2018","journal-title":"Dev Biol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4149\/neo_2016_403","article-title":"Malignant melanoma: diagnosis, treatment and cancer stem cells","volume":"63","author":"Kozovska","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.suc.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fnmol.2019.00111","article-title":"Stem cell-derived models of neural crest are essential to understand melanoma progression and therapy resistance","volume":"12","author":"Larrib\u00e8re","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"10.1016\/j.suc.2019.09.004_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s004030050446","article-title":"Determinants of melanocyte density in adult human skin","volume":"291","author":"Whiteman","year":"1999","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/oxfordjournals.aje.a112400","article-title":"Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States","volume":"105","author":"Fears","year":"1977","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clindermatol.2014.12.015","article-title":"Update on melanocytic nevi in children","volume":"33","author":"Schaffer","year":"2015","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07218.x","article-title":"Melanoma risk in congenital melanocytic naevi: a systematic review","volume":"155","author":"Krengel","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2012.05.043","article-title":"New recommendations for the categorization of cutaneous features of congenital melanocytic nevi","volume":"68","author":"Krengel","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.004_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0190-9622(98)70264-6","article-title":"Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients","volume":"39","author":"Egan","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.suc.2019.09.004_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0190-9622(97)80217-4","article-title":"A\u00a0study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature","volume":"36","author":"DeDavid","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0190-9622(98)70319-6","article-title":"Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study","volume":"39","author":"Sahin","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.suc.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0190-9622(95)90343-7","article-title":"The risk of melanoma in patients with congenital nevi: a cohort study","volume":"32","author":"Swerdlow","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/bjd.15301","article-title":"Melanoma in congenital melanocytic naevi","volume":"176","author":"Kinsler","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pcmr.12412","article-title":"Genetics of melanocytic nevi","volume":"28","author":"Roh","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"9","key":"10.1016\/j.suc.2019.09.004_bib18","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by post zygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsler","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.3928\/19382359-20160720-07","article-title":"Melanocytic nevi in children: a review","volume":"45","author":"Levy","year":"2016","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.suc.2019.09.004_bib20","series-title":"International classification of diseases for oncology","year":"2000"},{"issue":"23","key":"10.1016\/j.suc.2019.09.004_bib21","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMcp023017","article-title":"Clinical practice. Dysplastic nevi","volume":"349","author":"Naeyaert","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib22","doi-asserted-by":"crossref","first-page":"1.e1-16","DOI":"10.1016\/j.jaad.2012.02.047","article-title":"The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects","volume":"67","author":"Duffy","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.suc.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1993.01680310050007","article-title":"Role of sun exposure on nevus. First study in age-sex phenotype-controlled populations","volume":"129","author":"Richard","year":"1993","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.suc.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/1097-0142(19941215)74:12<3118::AID-CNCR2820741210>3.0.CO;2-7","article-title":"Dysplastic nevi as a melanoma risk factor in patients with familial melanoma","volume":"74","author":"Carey","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.suc.2019.09.004_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archderm.1991.01680060069006","article-title":"Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study","volume":"127","author":"Halpern","year":"1991","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib26","first-page":"591","article-title":"Melanomas of childhood","volume":"24","author":"Spitz","year":"1948","journal-title":"Am J Pathol"},{"key":"10.1016\/j.suc.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.141.11.1381","article-title":"The spectrum of Spitz nevi: a clinicopathologic study of 83 cases","volume":"141","author":"Ferrara","year":"2005","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.suc.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.5858\/arpa.2015-0207-RA","article-title":"Atypical spitz tumors: a diagnostic challenge","volume":"139","author":"Harms","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.det.2013.06.012","article-title":"Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview","volume":"31","author":"Ferrara","year":"2013","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cll.2017.05.003","article-title":"Toward a molecular-genetic classification of spitzoid neoplasms","volume":"37","author":"Tetzlaff","year":"2017","journal-title":"Clin Lab Med"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.path.2017.01.004","article-title":"Spitz tumors of the skin","volume":"10","author":"Menezes","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archderm.141.8.1032","article-title":"ABCDE--an evolving concept in the early detection of melanoma","volume":"141","author":"Rigel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.suc.2019.09.004_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A\u00a0study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma","volume":"15","author":"Clark","year":"1984","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pathol.2015.12.002","article-title":"Melanoma progression","volume":"48","author":"Elder","year":"2016","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/00313028509063771","article-title":"Malignant melanoma in\u00a0situ: the flat, curable stage of malignant melanoma","volume":"17","author":"Ackerman","year":"1985","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40257-013-0044-6","article-title":"Lentigo maligna: review of salient characteristics and management","volume":"14","author":"Kallini","year":"2013","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0190-9622(95)90282-1","article-title":"Lentigo maligna and lentigo maligna melanoma","volume":"33","author":"Cohen","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib38","first-page":"493","article-title":"Lentigo maligna\/lentigo maligna melanoma: current state of diagnosis and treatment","volume":"32","author":"McKenna","year":"2006","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.suc.2019.09.004_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/DSS.0000000000001493","article-title":"Evaluation of MITF, SOX10, MART-1, and R21 immunostaining for the diagnosis of residual melanoma in\u00a0situ on chronically sun-damaged skin","volume":"44","author":"Mu","year":"2018","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1524-4725.1995.tb00174.x","article-title":"The prognosis and treatment of true local cutaneous recurrent malignant melanoma","volume":"21","author":"Brown","year":"1995","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib41","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.suc.2019.09.004_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archderm.1980.01640310043015","article-title":"Acral lentiginous melanoma","volume":"116","author":"Coleman","year":"1980","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hoc.2009.03.013","article-title":"The classification of cutaneous melanoma","volume":"23","author":"Duncan","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.suc.2019.09.004_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40487-015-0012-9","article-title":"Reviewing challenges in the diagnosis and treatment of lentigo maligna and lentigo-maligna melanoma","volume":"3","author":"Juh\u00e1sz","year":"2015","journal-title":"Rare Cancers Ther"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00734848","article-title":"Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases","volume":"401","author":"S\u00f8ndergaard","year":"1983","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"5 Suppl 1","key":"10.1016\/j.suc.2019.09.004_bib46","first-page":"S78","article-title":"Melanoma survival in the United States, 1992 to 2005","volume":"65","author":"Pollack","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/CMR.0000000000000245","article-title":"Superficial spreading melanoma: an analysis of 97\u2009702 cases using the SEER database","volume":"26","author":"Singh","year":"2016","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molonc.2011.03.002","article-title":"Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care","volume":"5","author":"Scolyer","year":"2011","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib49","first-page":"39","article-title":"Lentigo maligna and lentigo-maligna melanoma","volume":"55","author":"Clark","year":"1969","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2340\/00015555-2855","article-title":"Nodular melanoma: a histopathologic entity?","volume":"98","author":"Green","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib53","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.path.2009.08.005","article-title":"Acral lentiginous melanoma","volume":"2","author":"Piliang","year":"2009","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/ced.13323","article-title":"Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management","volume":"43","author":"Desai","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.suc.2019.09.004_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anndiagpath.2016.08.005","article-title":"Histopathological diagnosis of acral lentiginous melanoma in early stages","volume":"26","author":"Fernandez-Flores","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11864-018-0560-y","article-title":"Diagnosis and management of acral lentiginous melanoma","volume":"19","author":"Nakamura","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjd.15600","article-title":"Prognostic factors and survival in acral lentiginous melanoma","volume":"177","author":"Asgari","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10137","key":"10.1016\/j.suc.2019.09.004_bib58","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(18)31071-7","article-title":"Acral lentiginous melanoma","volume":"391","author":"Liu","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1203475418800943","article-title":"Acral lentiginous melanoma: survival analysis of 715 cases","volume":"23","author":"Lino-Silva","year":"2019","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib60","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO;2-E","article-title":"Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma)","volume":"28","author":"Conley","year":"1971","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2012.10.041","article-title":"Desmoplastic melanoma: a review","volume":"68","author":"Chen","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.pap.0000155071.86944.a6","article-title":"Cutaneous desmoplastic melanoma","volume":"12","author":"Busam","year":"2005","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib63","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1245\/ASO.2006.03.091","article-title":"Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma","volume":"13","author":"Posther","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib64","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cncr.21635","article-title":"Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma","volume":"106","author":"Pawlik","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1245\/ASO.2005.12.914","article-title":"Desmoplastic melanoma: a heterogeneous entity in which subclassification as \"pure\" or \"mixed\" may have important prognostic significance","volume":"12","author":"Scolyer","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.004_bib66","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.pas.0000141391.91677.a4","article-title":"Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors","volume":"28","author":"Busam","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"10.1016\/j.suc.2019.09.004_bib67","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/cncr.25148","article-title":"Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients","volume":"116","author":"Murali","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib68","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of non cutaneous melanomas in the U.S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.004_bib69","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib70","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0194-59989570179-6","article-title":"Clinical and pathologic distinction between primary and metastatic mucosal melanoma of the head and neck","volume":"112","author":"Billings","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.suc.2019.09.004_bib71","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.5858\/2008-132-1623-COPAMM","article-title":"Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases","volume":"132","author":"Sanchez","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0046-8177(89)90135-4","article-title":"Primary malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas","volume":"20","author":"Fitzgibbons","year":"1989","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/apm.12529","article-title":"Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey","volume":"124","author":"Mikkelsen","year":"2016","journal-title":"APMIS"},{"issue":"15","key":"10.1016\/j.suc.2019.09.004_bib74","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: from diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.004_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajo.2015.11.005","article-title":"Fine needle aspiration biopsy in uveal melanoma: technique, complications, and outcomes","volume":"162","author":"Sellam","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"23","key":"10.1016\/j.suc.2019.09.004_bib76","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/aos.13452","article-title":"Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma","volume":"96","author":"Staby","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.suc.2019.09.004_bib78","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ophtha.2017.04.003","article-title":"Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 Harry S. Gradle Lecture","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","article-title":"Advances in the management of conjunctival melanoma","volume":"62","author":"Vora","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib80","first-page":"29","article-title":"Clinical management of uveal and conjunctival melanoma","volume":"30","author":"Blum","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.suc.2019.09.004_bib81","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.suc.2019.09.004_bib82","unstructured":"Smoller BR, Gershenwald JE, Scolyer RA, et\u00a0al. Protocol for the examination of specimens from patients with melanoma of the skin. Melanoma 4.0.0.0 (Posted June 2017). Based on AJCC\/UICC TNM, 8th edition. 2017 College of American Pathologists (CAP). June 2017."},{"issue":"19","key":"10.1016\/j.suc.2019.09.004_bib83","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1001\/jama.1982.03320440008004","article-title":"Melanoma thickness correlates with prognosis","volume":"247","author":"Cowart","year":"1982","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib84","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cam4.1320","volume":"7","author":"Namikawa","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib85","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib86","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CMR.0000000000000433","article-title":"Lymph node ratio as a prognostic factor in melanoma: results from European Organization for Research and Treatment of Cancer 18871, 18952, and 18991 studies","volume":"28","author":"Testori","year":"2018","journal-title":"Melanoma Res"},{"issue":"9","key":"10.1016\/j.suc.2019.09.004_bib87","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1245\/s10434-008-0024-x","article-title":"Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?","volume":"15","author":"Frankel","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2019.09.004_bib88","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamadermatol.2016.0875","article-title":"Acral lentiginous histologic subtype and sentinel lymph node positivity in thin melanoma","volume":"152","author":"Marek","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib89","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00000658-200201000-00012","article-title":"Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma","volume":"235","author":"Stojadinovic","year":"2002","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib90","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/cncr.20179","article-title":"Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluationimproves diagnostic precision","volume":"100","author":"Abrahamsen","year":"2004","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.suc.2019.09.004_bib91","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.ejca.2010.06.003","article-title":"EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria","volume":"46","author":"van der Ploeg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.suc.2019.09.004_bib92","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","article-title":"The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement","volume":"22","author":"Dewar","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/cup.13127","article-title":"Histological immune response patterns in sentinel lymph nodes involved by metastatic melanoma and prognostic significance","volume":"45","author":"Abbott","year":"2018","journal-title":"J\u00a0Cutan Pathol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib94","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/ijc.30563","article-title":"Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas","volume":"140","author":"Baum","year":"2017","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.suc.2019.09.004_bib95","first-page":"6825","article-title":"Complete lymph node dissection in melanoma: a systematic review and meta-analysis","volume":"37","author":"Delgado","year":"2017","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.suc.2019.09.004_bib96","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.medcli.2017.08.013","article-title":"Should immediate lymphadenectomy be discontinued in patients with metastasis of a melanoma in the sentinel lymph node? Report of the results of the Multicenter Selective Lymphadenectomy Trial-II","volume":"150","author":"Moreno-Ram\u00edrez","year":"2018","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib97","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib98","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejso.2016.10.005","article-title":"Diagnosis and treatment of in-transit melanoma metastasis","volume":"43","author":"Testori","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib99","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000658-198107000-00019","article-title":"Malignant melanoma. Prognostic significance of \"microscopic satellites\" in the reticular dermis and subcutaneous fat","volume":"194","author":"Day","year":"1981","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1245\/s10434-009-0350-7","article-title":"Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging","volume":"16","author":"Kimsey","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1245\/s10434-018-7006-4","article-title":"Microsatellitosis in Patients with Melanoma","volume":"26","author":"Karakousis","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.suc.2019.09.004_bib102","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0959-8049(03)00325-3","article-title":"Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas","volume":"39","author":"Spatz","year":"2003","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000362902","article-title":"Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients","volume":"229","author":"Munsch","year":"2014","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib104","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.surg.2015.12.002","article-title":"Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes","volume":"159","author":"Egger","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.suc.2019.09.004_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2015.11.014","article-title":"Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: ulceration of primary is key determinant for IFN-sensitivity","volume":"55","author":"Eggermont","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.suc.2019.09.004_bib106","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.surg.2018.04.016","article-title":"Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma","volume":"164","author":"Evans","year":"2018","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib107","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaad.2017.11.041","article-title":"Mitotic rate is associated with positive lymph nodes in patients with thin melanomas","volume":"78","author":"Wheless","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib108","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/ijd.13405","article-title":"Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma","volume":"56","author":"Tas","year":"2017","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.suc.2019.09.004_bib109","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e31822573f5","article-title":"Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34","volume":"35","author":"Rose","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.suc.2019.09.004_bib110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/DAD.0000000000000453","article-title":"Prognostic implication of lymphovascular invasion detected by double immunostaining for D2-40 and MITF1 in primary cutaneous melanoma","volume":"38","author":"Feldmeyer","year":"2016","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.004_bib111","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/modpathol.2017.76","article-title":"Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center","volume":"30","author":"Varey","year":"2017","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.004_bib112","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO;2-I","article-title":"Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma","volume":"76","author":"Baer","year":"1995","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.suc.2019.09.004_bib113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pathol.2015.12.006","article-title":"Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy","volume":"48","author":"Lee","year":"2016","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.suc.2019.09.004_bib114","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/CMR.0000000000000164","article-title":"Tumor-infiltrating lymphocytes predict cutaneous melanoma survival","volume":"25","author":"Fortes","year":"2015","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.suc.2019.09.004_bib115","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41467-017-00784-1","article-title":"Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat Commun"},{"issue":"6230","key":"10.1016\/j.suc.2019.09.004_bib116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.suc.2019.09.004_bib117","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/jdv.13815","article-title":"Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis","volume":"30","author":"Ribero","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.004_bib118","first-page":"638","article-title":"Prognostic role of histological regression in cutaneous melanoma","volume":"152","author":"Ribero","year":"2017","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.004_bib119","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/CMR.0000000000000277","article-title":"Presence of histological regression as a prognostic factor in cutaneous melanoma patients","volume":"26","author":"Tas","year":"2016","journal-title":"Melanoma Res"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610919301227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:11:28Z","timestamp":1758539488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610919301227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0039610919301227"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.004","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology of Melanoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}